Organoid culture
Sponsors
Chinese University of Hong Kong, The First Affiliated Hospital of Xiamen University, Qilu Hospital of Shandong University
Conditions
Bladder CancerKidney CancerOvarian Cancer
Unknown Phase
To Establish a Reproducible Organoid Culture Model With Human Kidney Cancer
CompletedNCT04342286
Start: 2020-05-01End: 2021-02-22Updated: 2021-12-16
Individualized Precision Treatment Based on Ovarian Cancer Organoid Model
NCT05813509
Start: 2022-12-01End: 2025-02-01Target: 30Updated: 2023-04-14
A Research Protocol for Evaluating the Efficacy of Perfused Chemotherapeutic Agents for Bladder Cancer Based on Organoid Technology
RecruitingNCT06662071
Start: 2024-10-01End: 2028-09-30Target: 293Updated: 2024-10-28
Evaluation of the Efficacy of Anti-HER2 Antibody-Drug Conjugates (ADC) in Locally Advanced or Metastatic Bladder Cancer Based on Organoid Technology.
RecruitingNCT07379268
Start: 2025-01-01End: 2028-12-31Target: 224Updated: 2026-01-30
Evaluating the Efficacy of Neoadjuvant Chemotherapy Drugs Based on Organoid Technology
RecruitingNCT07379281
Start: 2025-01-01End: 2030-12-31Target: 254Updated: 2026-01-30
Evaluation of Postoperative Adjuvant Chemotherapy Efficacy for Bladder Cancer Based on Organoid Technology.
RecruitingNCT07379255
Start: 2025-01-01End: 2030-12-31Target: 266Updated: 2026-01-30